
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Standard Life Aberdeen Plc | LSE:SLA | London | Ordinary Share | GB00BF8Q6K64 | ORD 13 61/63P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 274.10 | 273.20 | 273.40 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMSLA
RNS Number : 8204F
Standard Life Aberdeen plc
17 July 2019
Standard Life Aberdeen plc
Directorate change
The Board of Standard Life Aberdeen plc ('SLA') announces that Jonathan Asquith will be appointed as a Non-Executive Director with effect from 1 September 2019.
Jonathan Asquith brings a wealth of financial sector experience in both executive and non-executive directorship roles. In his executive career Jonathan worked at Morgan Grenfell for 18 years, rising to become Group Finance Director of Morgan Grenfell Group plc, before going on to take on the CFO roles at Deutsche Morgan Grenfell and subsequently Schroders plc. He also held leadership positions in Derivatives, Fixed Income, Equities and Private Banking. As a non-executive director, Jonathan has considerable relevant experience within the investment management and wealth industry having served, inter alia, on the Boards of Ashmore Group plc, Axa UK plc and Tilney Group Limited and as Chairman of Axa Investment Managers. He is currently Deputy Chairman of 3i Group plc, a position from which he is expected to retire next year.
Commenting on his appointment, Sir Douglas Flint, Chairman of SLA, said:
"I am very pleased to welcome Jonathan to our Board. His wide-ranging non-executive and executive experience across the financial services industry will bring further insight to our discussions".
On joining the Board, Jonathan will be appointed as the Senior Independent Director, a member and the Chair of the Remuneration Committee, and a member of the Nomination and Governance Committee.
Following this appointment, the Board will comprise four executive directors, six non-executive directors and the Chairman. The Board will be made up of four women and seven men. The Financial Conduct Authority and the Prudential Regulation Authority have been notified of this appointment and Jonathan's appointment as Chair of the Remuneration Committee is subject to regulatory approval. Jonathan's other appointments are listed below and no other information is required to be disclosed pursuant to paragraph LR 9.6.13R of the Listing Rules of the Financial Conduct Authority.
17 July 2019
Enquiries:
Media: +44 (0) 20 7463 6323 James Thorneley +44 (0) 7768 556 334 Institutional Equity Investors: +44 (0) 131 245 8028* Jakub Rosochowski +44 (0) 7515 298 608 Group Secretariat: Kenneth Gilmour +44 (0) 131 372 1175
* Calls may be monitored and/or recorded to protect both you and us and help with our training. Call charges will vary.
END
LEI number of Standard Life Aberdeen plc: 0TMBS544NMO7GLCE7H90
Classification: 3.1. Additional regulated information required to be disclosed under the laws of a Member State
Notes to Editors
Jonathan Asquith
Non-Executive Director's Fee
Jonathan's fee as a Non-Executive Director of SLA will be GBP73,500 per annum. His fee as Senior Independent Director will be GBP25,000. His fee as Chair of the Remuneration Committee will be GBP30,000 and his fee as a member of the Nomination and Governance Committee will be GBP10,000.
Interest in shares
As at the date of his appointment, Jonathan does not hold any shares in Standard Life Aberdeen plc.
Biographical details: Nationality: British Education/Qualifications: University of Cambridge, MA Law, (1978) Inns of Court School of Law: Bar Finals (1979) Other Non-Executive Appointments: 2018 - Present Tilney Group Limited, Chair of Audit Committee 2015 - Present CiCap Limited (parent company of Coller Capital) 2011 - Present 3i Group plc, Deputy Chairman and SID and Chair of Remuneration Committee Previous Experience Formerly Chairman of Citigroup Global Markets Limited, Citibank International plc, Dexion Capital plc and AXA Investment Managers. Non-executive director of Ashmore Group plc and Axa UK plc. Director of Schroders plc from 2002 to 2008, during which time he was Chief Financial Officer and later executive Vice Chairman. Previously in investment banking with Morgan Grenfell and Deutsche Bank.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
BOAGGUQGMUPBURM
(END) Dow Jones Newswires
July 17, 2019 04:19 ET (08:19 GMT)
1 Year Standard Life Aberdeen Chart |
1 Month Standard Life Aberdeen Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions